Basic information

Biomarker: ECM1

Histology type: endometrial clear cell carcinoma

Cohort characteristics

Country: UK

Study type: prospective case-control study

Followed up time :

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
100 EC 50 controls 50

Sample information

Conclusion: A patient-friendly, urine-based test could offer a non-invasive endometrial cancer detection tool in symptomatic women. Validation in a larger independent cohort is warranted.

Sample type : urine

Sample method: mass spectrometric analysis

Disease information

Related information

Funtion Uniprot: Involved in endochondral bone formation as negative regulator of bone mineralization. Stimulates the proliferation of endothelial cells and promotes angiogenesis. Inhibits MMP9 proteolytic activity

UniProt ID: Q16610

UniProt Link: https://www.uniprot.org/uniprotkb/Q16610

Biological function from UniProt: #Angiogenesis #Biomineralization #Mineral balance #Osteogenesis

Molecular function from UniProt:

Tissue specificity from UniProt: Expressed in breast cancer tissues. Little or no expression observed in normal breast tissues. Expressed in skin; wide expression is observed throughout the dermis with minimal expression in the epidermis.

Subcellular UniProt: #Extracellular matrix #Secreted

Alternative name from UniProt:

Recommended name: Extracellular matrix protein 1

Gene name from HGNC: ECM1

HPA class: Disease related genes Human disease related genes Plasma proteins

AlphaFold DB: Q16610

AlphaFold Link: https://alphafold.ebi.ac.uk/entry/Q16610

HPA link: https://www.proteinatlas.org/ENSG00000143369-ECM1

Tissue specificity RNA from HPA: Tissue enhanced (epididymis, esophagus)

Tissue expression from HPA: Squamous epithelium - Keratinization (mainly)

Single cell type specificity Cell type enhanced (Suprabasal keratinocytes, Fibroblasts, Endometrial stromal cells, Melanocytes)

Immune cell specificity: Not detected in immune cells

Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), urothelial cancer (unfavorable) and pancreatic cancer (unfavorable)

Pathology link: https://www.proteinatlas.org/ENSG00000143369-ECM1/pathology

Pathology endo: https://www.proteinatlas.org/ENSG00000143369-ECM1/pathology/endometrial+cancer

OMIM: 602201

OMIM link2: https://www.omim.org/entry/602201

HGNC ID: HGNC:3153

HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3153

Visulization